Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 20921462

Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2010 Nov 1
First author
Peeters M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2010 Nov 1;28(31):4668-70. doi: 10.1200/JCO.2010.29.3407.
    note
    Source null
    related pmid
    20921457
    relationship
    Comment in

Authors and identifiers

  1. name
    Peeters M
    type
    Author
  2. name
    Price TJ
    type
    Author
  3. name
    Cervantes A
    type
    Author
  4. name
    Sobrero AF
    type
    Author
  5. name
    Ducreux M
    type
    Author
  6. name
    Hotko Y
    type
    Author
  7. name
    André T
    type
    Author
  8. name
    Chan E
    type
    Author
  9. name
    Lordick F
    type
    Author
  10. name
    Punt CJ
    type
    Author
  11. name
    Strickland AH
    type
    Author
  12. name
    Wilson G
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Peeters M
    type
    Author
  2. name
    Price TJ
    type
    Author
  3. name
    Cervantes A
    type
    Author
  4. name
    Sobrero AF
    type
    Author
  5. name
    Ducreux M
    type
    Author
  6. name
    Hotko Y
    type
    Author
  7. name
    André T
    type
    Author
  8. name
    Chan E
    type
    Author
  9. name
    Lordick F
    type
    Author
  10. name
    Punt CJ
    type
    Author
  11. name
    Strickland AH
    type
    Author
  12. name
    Wilson G
    type
    Author
bibliography ids
  1. nci-bib-20fe5af9bfa3c550f90a9bf5
book metadata
content sha256
33edc1395974db6ba1f331143f738e073656a4f8b2f8bc2a1a8dcb317d7de9fb
document type
citation
dois
  1. 10.1200/JCO.2009.27.6055
electronic publication date
display
2010 Oct 4
precision
day
year
2010
evidence scope
bibliographic_metadata_only
id
pubmed:20921462
immutable id
pubmed:20921462@33edc1395974db6ba1f331143f738e073656a4f8b2f8bc2a1a8dcb317d7de9fb
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
31
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
4706-13
volume
28
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2010 Nov 1;28(31):4668-70. doi: 10.1200/JCO.2010.29.3407.
    note
    Source null
    related pmid
    20921457
    relationship
    Comment in
outcomes validated
false
pmid
20921462
provenance
batch id
10a38257e12e9ed1867a
provider
NCBI PubMed ESummary
record sha256
a60df6e904748d57b1a74a055269ce3e1860157472fca4bb8a17e3c90d82ed58
response sha256
84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
retrieved at
2026-09-09T23:46:35.793530+00:00
publication date
display
2010 Nov 1
precision
day
year
2010
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/20921462/
title
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.

Preserved source evidence · Independent clinical review pending · Not medical advice